Insider trade

Orchestra Biomed Holdings (OBIO): CFO received 181K shares

Andrew Lawrence Taylor, CFO at Orchestra Biomed Holdings, reported a grant / award of 181K shares.

181K
Shares

Traded: Feb 12, 2026
Filed: Feb 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Feb 12, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 12, 2026, the Board of Directors (the “ Board ”) of Orchestra BioMed Holdings, Inc. (the “ Company ”), upon the recommendation of the Compensation Committee of the Board (the “ Compensation Committee ”), approved the 2026 cash bonus plan for all executive officers (the “ Plan ”), which: · establishes annual goals with mid-year key deliverables approved by the Committee or the Board; · provides for a…”

What came next

Mar 13, 2026InsiderDirector purchased ~$43K of OBIO shares in the open market
Apr 27, 2026Insider10% owner sold ~$132 of OBIO shares in the open market
May 14, 2026InsiderDirector purchased ~$83K of OBIO shares in the open market
May 15, 2026Insider · 2 peopleInsiders: 2 purchases (~$54K)
May 18, 2026Insider · 3 insiders in a week, 3rd time since 2020Director purchased ~$2.5K of OBIO shares in the open market
Jun 1, 2026Insider · 2 peopleInsiders: 1 purchase (~$19K), 1 sale (~$58K)

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Orchestra Biomed Holdings

For Orchestra Biomed Holdings, OQRO holds 11 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its OBIO page.

Other recent filings by Andrew Lawrence Taylor, Chief Financial Officer

The full history of Andrew Lawrence Taylor, Chief Financial Officer is on the profile page.

How this filing works

Explore the data

Other disclosures at Orchestra Biomed Holdings

Everything OQRO holds on this company is on its OBIO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data